Quercis Pharma AG is a private Swiss biotech company advancing a novel antithrombotic in multiple indications: the lead program is prevention of Venous Thrombosis Embolism in advanced cancer patients (phase III) followed by clinical trials in Sickle Cell Disease (phase II) and Covid-19 (phase II).

Location

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2018
  • Number of employees in Switzerland
    1-9

Key business

Keep browsing

You may also be interested in